Ser154
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser154  -  CCNA2 (human)

Site Information
PMDGSFEsPHTMDMS   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 3140800

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 2 ) , phospho-antibody ( 1 ) , phosphoamino acid analysis ( 2 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
CDK2 (human) ( 2 )
Kinases, in vitro:
CDK2 (human) ( 2 )
Treatments:
MK1775 ( 1 )

References 

1

Gheghiani L, et al. (2017) PLK1 Activation in Late G2 Sets Up Commitment to Mitosis. Cell Rep 19, 2060-2073
28591578   Curated Info

2

Yam CH, Siu WY, Lau A, Poon RY (2000) Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J Biol Chem 275, 3158-67
10652300   Curated Info